🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase one study to assess the safety of daily dosing of Lactobaci...
Status
Completed
Location
Community of Santa Clara
Start Date
2010-02
Trial ID
NCT00774163
Treatments Being Tested
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
The goal of this randomized clinical trial is to learn if topical treatment...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2025-08-25
Trial ID
NCT06830863
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
Dyspepsia refers to chronic or recurrent upper gastrointestinal (GI) sympto...
Status
Recruiting
Location
KU Leuven
Start Date
2024-10-01
Trial ID
NCT06482671
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
To compare responses to acute oral doses of ethanol in healthy young adults...
Status
Completed
Location
University of Chicago
Start Date
2019-05-28
Trial ID
NCT03964350
The purpose of this study is to assess the efficacy and safety of pimecroli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2004-12
Trial ID
NCT00510003
Treatments Being Tested
This is a randomized double-blind vehicle-controlled Phase 3 study to evalu...
Status
Completed
Location
Dermavant Investigative Site
Start Date
2019-06-06
Trial ID
NCT03983980
Treatments Being Tested